In 2003, researchers from Italy identified autoantibodies produced in CS patients against a “Cogan peptide,” which shared homology with laminin, connexin 26, cell density-enhanced protein tyrosine phosphatase-1 (DEP-1/CD148), SSA/Ro, and reovirus III major core protein lambda 1. This evidence concerns the gene CALR and Cowden syndrome 1.